Sarepta Therapeutics, Inc. - COM (SRPT)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
85.8M
Holdings value Q3 2024
$10.7B
Value change Q3 2024
-$609M
Grand Portfolio weight change Q3 2024
-0.001%
Number of holders
448
Number of buys Q3 2024
220
Number of sells Q3 2024
-235
Average buys Q3 2024 %
+0.003%
Average sells Q3 2024 %
-0.007%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 85.8M $10.7B -$609M $124.89 453
2024 Q2 88.8M $14B +$1.08B $158.00 484
2024 Q1 81.7M $10.6B +$129M $129.46 408
2023 Q4 80.5M $7.76B -$212M $96.43 395
2023 Q3 81.4M $9.86B +$115M $121.22 393
2023 Q2 80.9M $9.27B +$53.2M $114.52 406
2023 Q1 80.5M $11.1B +$320M $137.83 422
2022 Q4 78.2M $10.1B +$98.8M $129.58 410
2022 Q3 77.5M $8.57B +$579M $110.54 366
2022 Q2 72.5M $5.43B +$35.8M $74.96 314
2022 Q1 72.2M $5.64B +$61.6M $78.12 315
2021 Q4 71M $6.39B +$536M $90.05 328
2021 Q3 64.9M $6B +$127M $92.48 298
2021 Q2 64M $4.97B -$97.4M $77.74 317
2021 Q1 65.6M $4.89B -$733M $74.53 344
2020 Q4 70.2M $12B -$162M $170.49 439
2020 Q3 71.7M $10.1B -$332M $140.43 400
2020 Q2 73.5M $11.8B +$155M $160.34 403
2020 Q1 73M $7.14B -$32.1M $97.82 349
2019 Q4 72.9M $9.41B +$53.4M $129.04 386
2019 Q3 72.7M $5.48B -$253M $75.32 339
2019 Q2 71.2M $10.8B +$291M $151.95 358
2019 Q1 70.5M $8.42B +$289M $119.19 361
2018 Q4 68.2M $7.44B +$727M $109.13 332
2018 Q3 61.2M $9.88B +$246M $161.51 344
2018 Q2 60M $7.92B +$549M $132.18 315
2018 Q1 56.8M $4.2B +$182M $74.09 270
2017 Q4 55.2M $3.07B +$54.9M $55.64 248
2017 Q3 53.7M $2.44B +$522M $45.36 226
2017 Q2 42.6M $1.44B +$79.9M $33.71 185
2017 Q1 40.7M $1.21B +$219M $29.60 175
2016 Q4 39.5M $1.08B -$170M $27.43 175
2016 Q3 42.4M $2.6B +$576M $61.41 182
2016 Q2 34.6M $660M -$14.4M $19.07 142
2016 Q1 35.1M $686M +$88.7M $19.52 129
2015 Q4 28.5M $1.1B +$34.5M $38.58 148
2015 Q3 27.8M $892M +$35.1M $32.11 146
2015 Q2 26.7M $811M +$87.3M $30.43 127
2015 Q1 24.2M $321M -$7.3M $13.28 114
2014 Q4 24.7M $357M -$43.9M $14.47 118
2014 Q3 26M $548M -$18.5M $21.10 122
2014 Q2 26.6M $794M +$919K $29.79 125
2014 Q1 26.6M $639M -$12.4M $24.03 114